112 related articles for article (PubMed ID: 24909193)
1. Outcome of patients with severe PH due to lung disease with and without targeted therapy.
Lange TJ; Baron M; Seiler I; Arzt M; Pfeifer M
Cardiovasc Ther; 2014 Oct; 32(5):202-8. PubMed ID: 24909193
[TBL] [Abstract][Full Text] [Related]
2. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
[TBL] [Abstract][Full Text] [Related]
3. Udenafil improves exercise capacity in patients with chronic obstructive pulmonary disease: a prospective study.
Park JS; Lim HJ; Cho YJ; Lee JH; Yoon HI; Lee CT
COPD; 2012 Aug; 9(5):499-504. PubMed ID: 22946546
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
[TBL] [Abstract][Full Text] [Related]
5. The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study.
Reichenbach A; Al-Hiti H; Malek I; Pirk J; Goncalvesova E; Kautzner J; Melenovsky V
Int J Cardiol; 2013 Sep; 168(1):60-5. PubMed ID: 23058346
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based pharmacologic management of pulmonary arterial hypertension.
Benedict N; Seybert A; Mathier MA
Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
[TBL] [Abstract][Full Text] [Related]
7. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study.
Deaño RC; Glassner-Kolmin C; Rubenfire M; Frost A; Visovatti S; McLaughlin VV; Gomberg-Maitland M
JAMA Intern Med; 2013 May; 173(10):887-93. PubMed ID: 23568223
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in cystic fibrosis with advanced lung disease.
Hayes D; Tobias JD; Mansour HM; Kirkby S; McCoy KS; Daniels CJ; Whitson BA
Am J Respir Crit Care Med; 2014 Oct; 190(8):898-905. PubMed ID: 25222938
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation.
Hayes D; Black SM; Tobias JD; Mansour HM; Whitson BA
COPD; 2016; 13(1):50-6. PubMed ID: 26366936
[TBL] [Abstract][Full Text] [Related]
10. Severe pulmonary hypertension in lung disease: phenotypes and response to treatment.
Brewis MJ; Church AC; Johnson MK; Peacock AJ
Eur Respir J; 2015 Nov; 46(5):1378-89. PubMed ID: 26293503
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
12. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension.
Grünig E; Ehlken N; Ghofrani A; Staehler G; Meyer FJ; Juenger J; Opitz CF; Klose H; Wilkens H; Rosenkranz S; Olschewski H; Halank M
Respiration; 2011; 81(5):394-401. PubMed ID: 21311162
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
Bharani A; Mathew V; Sahu A; Lunia B
Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary hypertension in Russia: the first results of the national register].
Chazova IE; Arkhipova OA; Valieva ZS; Nakonechnikov SN; Martyniuk TV
Ter Arkh; 2014; 86(9):56-64. PubMed ID: 25518507
[TBL] [Abstract][Full Text] [Related]
16. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
17. Survival in schistosomiasis-associated pulmonary arterial hypertension.
dos Santos Fernandes CJ; Jardim CV; Hovnanian A; Hoette S; Dias BA; Souza S; Humbert M; Souza R
J Am Coll Cardiol; 2010 Aug; 56(9):715-20. PubMed ID: 20723801
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension.
Nickel N; Golpon H; Greer M; Knudsen L; Olsson K; Westerkamp V; Welte T; Hoeper MM
Eur Respir J; 2012 Mar; 39(3):589-96. PubMed ID: 21885392
[TBL] [Abstract][Full Text] [Related]
19. Influence of pulmonary hypertension on survival in advanced lung disease.
Hayes D; Black SM; Tobias JD; Mansour HM; Whitson BA
Lung; 2015 Apr; 193(2):213-21. PubMed ID: 25787084
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension.
Sadushi-Koliçi R; Skoro-Sajer N; Zimmer D; Bonderman D; Schemper M; Klepetko W; Glatz J; Jakowitsch J; Lang IM
J Heart Lung Transplant; 2012 Jul; 31(7):735-43. PubMed ID: 22480725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
